Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy
Open Access
- 16 February 2021
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 10 (2), 296
- https://doi.org/10.3390/antiox10020296
Abstract
Sickle cell disease (SCD) is the most common hereditary disorder of hemoglobin (Hb), which affects approximately a million people worldwide. It is characterized by a single nucleotide substitution in the β-globin gene, leading to the production of abnormal sickle hemoglobin (HbS) with multi-system consequences. HbS polymerization is the primary event in SCD. Repeated polymerization and depolymerization of Hb causes oxidative stress that plays a key role in the pathophysiology of hemolysis, vessel occlusion and the following organ damage in sickle cell patients. For this reason, reactive oxidizing species and the (end)-products of their oxidative reactions have been proposed as markers of both tissue pro-oxidant status and disease severity. Although more studies are needed to clarify their role, antioxidant agents have been shown to be effective in reducing pathological consequences of the disease by preventing oxidative damage in SCD, i.e., by decreasing the oxidant formation or repairing the induced damage. An improved understanding of oxidative stress will lead to targeted antioxidant therapies that should prevent or delay the development of organ complications in this patient population.This publication has 176 references indexed in Scilit:
- N-acetylcysteine reduces oxidative stress in sickle cell patientsAnnals of Hematology, 2012
- The Novel Function of Advanced Glycation End Products in Regulation of MMP-9 ProductionJournal of Surgical Research, 2011
- Peroxiredoxin-2 expression is increased in β-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stressFree Radical Biology & Medicine, 2010
- Oxidized Low-Density LipoproteinPublished by Springer Science and Business Media LLC ,2009
- Tetrahydrobiopterin, superoxide, and vascular dysfunctionFree Radical Biology & Medicine, 2009
- Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patientsTranslational Research, 2008
- Heme degradation and oxidative stress in murine models for hemoglobinopathies: Thalassemia, sickle cell disease and hemoglobin C diseaseBlood Cells, Molecules, and Diseases, 2008
- Rate of nitric oxide scavenging by hemoglobin bound to haptoglobinNitric Oxide, 2008
- Protective effect of arginine on oxidative stress in transgenic sickle mouse modelsFree Radical Biology & Medicine, 2006
- Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemiasFree Radical Biology & Medicine, 2006